Skip to main content
Top
Published in: Supportive Care in Cancer 4/2019

01-04-2019 | Original Article

Urine cultures at the onset of febrile neutropenia rarely impact antibiotic management in asymptomatic adult cancer patients

Authors: Sam E. Grigg, Patrick Date, Zoe Loh, Ortis Estacio, Douglas F. Johnson, Eliza A. Hawkes, Andrew Grigg

Published in: Supportive Care in Cancer | Issue 4/2019

Login to get access

Abstract

Purpose

There is a paucity of data regarding the utility of routine urine cultures in adults with febrile neutropenia (FN) without urinary symptoms receiving protocolised antibiotics. This is reflected by inconsistent recommendations in international and regional FN guidelines. We addressed this issue by retrospectively reviewing the impact of routine urine cultures on antibiotic management in haematology cancer inpatients at a tertiary hospital.

Methods

All haematology inpatients over a 5-year period (2011–2015) were retrospectively reviewed for episodes of FN (neutrophil count < 0.5 × 109/L and fever > 37.5 °C). For each episode, demographic data, urinary tract symptoms and signs (absence of which was termed ‘asymptomatic’), urinalysis and urine culture results, antibiotic therapy and duration, and patient outcomes were collected. A urine culture was considered positive if > 105 colony forming units (CFU)/L were detected. Empiric antibiotic therapy for FN consisted of intravenous piperacillin/tazobactam in stable patients, with the addition of vancomycin and a single dose of gentamicin if systemically compromised.

Results

Four hundred and thirty-three episodes of FN were identified in 317 patients. Urine cultures were performed in 362 (84%) episodes. Cultures were positive in 9 of 48 (19%) symptomatic episodes versus 8 of 314 (2.5%) asymptomatic episodes (RR = 7.4, p < 0.0001). A change in antibiotic management due a positive urine culture occurred in only 5 episodes (1.4%): 3 of 48 (6.3%) symptomatic and 2 of 314 (0.6%) asymptomatic episodes respectively (RR = 9.8, p = 0.01).

Conclusion

Routine urine cultures in FN patients without urinary symptoms who are already receiving protocolised broad spectrum antibiotics rarely impact subsequent antibiotic management.
Appendix
Available only for authorised users
Literature
1.
go back to reference Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of Americaa (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:427–431CrossRefPubMed Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of Americaa (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:427–431CrossRefPubMed
2.
go back to reference Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, Herrstedt J, ESMO Guidelines Committee (2016) Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol 27:v111–v1v8CrossRefPubMed Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, Herrstedt J, ESMO Guidelines Committee (2016) Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol 27:v111–v1v8CrossRefPubMed
3.
go back to reference Masaoka T (2004) Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary. Clin Infect Dis 39:S49–S52CrossRefPubMed Masaoka T (2004) Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary. Clin Infect Dis 39:S49–S52CrossRefPubMed
9.
go back to reference Chan W (2016) Urine cultures. In: Leber A (ed) Clinical microbiology procedures handbook, 4th edn. ASM Press, Washington 3.12.6 Chan W (2016) Urine cultures. In: Leber A (ed) Clinical microbiology procedures handbook, 4th edn. ASM Press, Washington 3.12.6
12.
go back to reference Wong M, Barqasho B, Öhrmalm L, Tolfvenstam T, Nowak P (2013) Microbial translocation contribute to febrile episodes in adults with chemotherapy-induced neutropenia. PLoS One 8:e68056CrossRefPubMedPubMedCentral Wong M, Barqasho B, Öhrmalm L, Tolfvenstam T, Nowak P (2013) Microbial translocation contribute to febrile episodes in adults with chemotherapy-induced neutropenia. PLoS One 8:e68056CrossRefPubMedPubMedCentral
13.
go back to reference Steinrucken J, Pabst T, Zimmerli S, Marschall J (2016) Low impact of urine cultures as a diagnostic tool in patients with neutropenic fever. Infect Dis (Lond) 48:872–874CrossRef Steinrucken J, Pabst T, Zimmerli S, Marschall J (2016) Low impact of urine cultures as a diagnostic tool in patients with neutropenic fever. Infect Dis (Lond) 48:872–874CrossRef
14.
go back to reference Hooton TM, Roberts PL, Cox ME, Stapleton AE (2013) Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med 369:1883–1891CrossRefPubMedPubMedCentral Hooton TM, Roberts PL, Cox ME, Stapleton AE (2013) Voided midstream urine culture and acute cystitis in premenopausal women. N Engl J Med 369:1883–1891CrossRefPubMedPubMedCentral
15.
go back to reference Weinkove R, Clay J, Wood C (2013) Temperature management in haematology patients with febrile neutropenia: a practice survey. N Z Med J 126:62–73PubMed Weinkove R, Clay J, Wood C (2013) Temperature management in haematology patients with febrile neutropenia: a practice survey. N Z Med J 126:62–73PubMed
16.
go back to reference Frimodt-Møller N (2002) Correlation between pharmacokinetic/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection. Int J Antimicrob Agents 19:546–553CrossRefPubMed Frimodt-Møller N (2002) Correlation between pharmacokinetic/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection. Int J Antimicrob Agents 19:546–553CrossRefPubMed
17.
go back to reference Klaassen IL, de Haas V, van Wijk JA, Kaspers GJ, Bijlsma M, Bokenkamp A (2011) Pyuria is absent during urinary tract infections in neutropenic patients. Pediatr Blood Cancer 56:868–870CrossRefPubMed Klaassen IL, de Haas V, van Wijk JA, Kaspers GJ, Bijlsma M, Bokenkamp A (2011) Pyuria is absent during urinary tract infections in neutropenic patients. Pediatr Blood Cancer 56:868–870CrossRefPubMed
Metadata
Title
Urine cultures at the onset of febrile neutropenia rarely impact antibiotic management in asymptomatic adult cancer patients
Authors
Sam E. Grigg
Patrick Date
Zoe Loh
Ortis Estacio
Douglas F. Johnson
Eliza A. Hawkes
Andrew Grigg
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4476-7

Other articles of this Issue 4/2019

Supportive Care in Cancer 4/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine